Jaypee Brothers
In Current Chapter
In All Chapters
X
Clear
X
GO
Normal
Sepia
Dark
Default Style
Font Style 1
Font Style 2
Font Style 3
Less
Normal
More
Menopause
Neerja Goel, Bindiya Gupta
SECTION I: BASIC SCIENCES
CHAPTER 1:
Definitions and Epidemiology
INTRODUCTION
DEMOGRAPHICS
DEFINITIONS
STAGES OF REPRODUCTIVE AGING
AGE OF MENOPAUSE
Trends in Age at Menopause
Factors Affecting Timing of Menopause
Factors Affecting Oocyte Survival and Co-relation with Menstrual Cycles
Genetic Factors and Heritability
Race and Ethinicity
Hormonal Exposures
Socioeconomic Factor
Psychological Factors/Stress
Body Mass Index/Obesity
Diet
Smoking and Alcohol
Others
EPIDEMIOLOGY OF MENOPAUSAL SYMPTOMS
Vasomotor Symptoms
Psychological Symptoms
Sexual Dysfunction
Chronic Conditions Affecting Postmenopausal Health
KEY POINTS
CHAPTER 2:
Pathophysiology of Menopause
FOLLICLE POPULATION
OVARIAN-PITUITARY-HYPOTHALAMIC AXIS
PERIMENOPAUSE
HORMONAL CHANGES DURING MENOPAUSE
Gonadotropins
Androgens
Estrogen
Progesterone
Inhibin and Anti-Müllerian Hormone
IMPACT OF ESTROGEN DEFICIENT ENDOCRINOPATHY
Decline in Fertility
Menstrual Changes During Perimenopause
Cardiovascular Changes
Vasomotor Symptoms
Pathophysiology
Atrophic and Urogenital Changes
Breast Changes
Psychological Changes
Depression
Concentration and Memory
Sleep Disturbances
Bone Changes
KEY POINTS
CHAPTER 3:
Symptoms and Signs
PERIMENOPAUSE
Menstrual Disturbances and Infertility
Vasomotor Symptoms
Sleep Disturbances
Mood Disorders
Others
MENOPAUSE
Vasomotor Symptoms
Sleep Disturbances
Urogenital and Sexual Problems
Musculoskeletal Problems
Osteoporosis
Frailty
Dementia and Cognition
Orodental Problems
Skin and Hair Problems
Eye Problems
MEASUREMENT OF MENOPAUSAL SYMPTOMS
KEY POINTS
CHAPTER 4:
Cancer Screening
SCREENING OF CANCER CERVIX
Screening Tests
Direct Visual Inspection
Visual Inspection with Acetic Acid
Visual Inspection with Lugol's Iodine
Cervical Cytology
Human Papillomavirus Testing
Screening Guidelines
Colposcopy
SCREENING FOR ENDOMETRIAL CANCER
Screening Modalities
Screening Guidelines 22
Screening of Average Risk and Increased Risk Asymptomatic Women
Screening of Women at Very High Risk
SCREENING FOR OVARIAN CANCER
Ovarian Cancer Screening Tests
Pelvic Examination
Tumor Markers
Surface Enhanced Laser Desorption Ionization Time of Flight (SELDI TOF)
Transvaginal Ultrasound
Multimodal Screening
Trials on Screening in Ovarian Cancer
Screening Guidelines
For Low Risk Women
Women with Increased Risk
SCREENING OF BREAST CANCER
Breast Cancer and Hormone Therapy
Screening Modalities
Mammography
Digital Mammography
Breast Self-examination and Clinical Breast Examination
Ultrasonography
Magnetic Resonance Imaging
Screening Guidelines
American College of Obstetricians and Gynecologists Guidelines for Screening of Breast Cancer in Menopausal Female 59
KEY POINTS
SECTION II: HORMONE THERAPY
CHAPTER 5:
Pretreatment Evaluation
PATIENT ASSESSMENT
History
Health Promotion
Examination
Investigations
KEY POINTS
CHAPTER 6:
Guidelines for Hormone Therapy
ESTROGENS
Physiology and Mechanism of Action
Pharmaceutical Preparations of Estrogen
Oral Estrogens
Transdermal Estrogen
Topical Estradiol
Vaginal Estrogens
Vaginal Ring
Use in Vaginal Atrophy
Dose Equivalents
PROGESTOGEN
Side Effects
Commonly Used Progestogens
Medroxyprogesterone Acetate
Natural Progesterone
Levonorgestrel Intrauterine Device
Drospirenone (DRSP)
DOSES AND ESTROGEN: PROGESTOGEN REGIMENS
Unopposed Estrogen
Cyclic Sequential Regimen
Continuous Sequential Regimen
Cyclic Combined Regimen
Continuous Combined Regimens
Quarterly Progestin or Long Cycle Hormone Therapy
STARTING HORMONE THERAPY
MONITORING
DURATION
DISCONTINUING HORMONE THERAPY
HORMONE THERAPY TRIALS
Women's Health Initiative Trials
Million Women Study
Hormone Therapy and Breast Cancer
Hormone Therapy and Endometrial Cancer
Hormone Therapy and Ovarian Cancer
ANDROGEN THERAPY
TIBOLONE
Tibolone Regime
ROLE OF ORAL CONTRACEPTIVES DURING THE PERIMENOPAUSE
BIOIDENTICAL HORMONE THERAPY
BENEFITS OF HORMONE THERAPY
Vasomotor Symptoms
Vaginal Symptoms
Sexual Function
Urinary Tract Health
Quality of Life
Osteoporosis
Mood and Depression
Cognitive Aging and Dementia
Colorectal Cancer
Cardioprotection
ADVERSE EFFECTS OF HORMONE THERAPY
Stroke
Venous Thromboembolism
Cardiovascular Effects
Endometrial Cancer
Breast Cancer
HORMONE THERAPY IN SPECIAL CONDITIONS
Premature Ovarian Insufficiency
Turner's Syndrome
Dose
Progestogens
Hormone Therapy After Cancer
Endometrial Cancer
Breast Cancer
Ovarian Cancer
Cervical Cancer
Vulvar Cancer
KEY POINTS
CHAPTER 7:
Vasomotor Symptoms
INCIDENCE
Occurrence of Hot Flush
PATHOPHYSIOLOGY OF HOT FLUSHES
Role of Norepinephrine
Role of Core Body Temperature
LH and GnRH Pulse
MANAGEMENT
Hormone Therapy
Tibolone
Non-hormonal Therapies
Bioidentical Hormone Therapy
KEY POINTS
CHAPTER 8:
Osteoporosis
DEFINITION
World Health Organization Criteria for Classification of Osteoporosis
EPIDEMIOLOGY
Prevalence
Morbidity and Mortality
PATHOPHYSIOLOGY
Estrogen Regulation on Bone Metabolism
RISK FACTORS FOR OSTEOPOROTIC FRACTURE
Age
Body Mass Index and Thinness
Bone Mineral Density and Fracture Risk
Genetics
Menopausal Status
Fracture History
Lifestyle Factors
Secondary Causes of Bone Loss
Risk of Falling
Limitation of Risk Factors
EVALUATION
History and Physical Examination
Spine Imaging
Bone Mineral Density Measurement
Indications for Bone Mineral Density Testing
Bone Mineral Density Measurement Sites
Bone Density Reports
Follow-up
Bone Turnover Markers
Tests for Secondary Causes
MANAGEMENT
Life Style and Nonpharmacological Measures for Bone Health
Good General Nutrition
Calcium and Vitamin D
Other Nutrients
Exercise
Fall Prevention
Pharmacological Therapy
Bisphosphonates
Raloxifene
Teriparatide (Recombinant Human PTH 1–34)
Calcitonin
Hormonal Therapy
Tibolone
Combination Therapies
Sequential Use of Therapeutic Agents
Promising New Therapies
KEY POINTS
CHAPTER 9:
Urogenital and Sexual Symptoms
PREVALENCE
PATHOPHYSIOLOGY
Vulvovaginal Changes
Urinary Tract Changes
Risk Factors
SYMPTOMATOLOGY
PATIENT EVALUATION
History
Examination
Investigations
TREATMENT
Hormonal Therapy
Systemic Estrogen Therapy
Local Vaginal Estrogen Therapy
Testosterone
Tibolone
Emerging Hormonal Treatment Options
Nonhormonal Treatment
Lifestyle Modifications
PATIENT COUNSELING AND FOLLOW-UP
SUMMARIES OF VARIOUS MENOPAUSE SOCIETIES ON MANAGEMENT OF UROGENITAL AND SEXUAL SYMPTOMS IN MENOPAUSE
KEY POINTS
CHAPTER 10:
End Organ and Connective Tissues
MENOPAUSE AND SKIN
Skin Physiology and the Role of Estrogen
Effects of Menopause on Skin
Effects of Estrogen Deficiency on Physical Characteristics of Skin
Skin Thickness
Elasticity and Distensibility
Wrinkles
Dry Skin
Sebaceous Secretions
Delayed Wound Healing
Effect of Hormone Therapy on Skin
Skin Surface Lipids
Epidermal Hydration
Collagen and Skin Thickness
Skin Elasticity and Wrinkles
Wound Healing
Alternatives to Conventional Hormone Therapy
Topical Hormone Therapy
Selective Estrogen Receptor Modulators
Phytoestrogens
MENOPAUSE AND HAIR
Climacteric Hair Loss
Clinical Features
Role of Hormones in Female Pattern Alopecia
Frontal Fibrosing Alopecia
Climacteric Facial Hirsutism
Treatment of Female Pattern Alopecia
Minoxidil
Finasteride
MENOPAUSE AND ORAL CAVITY
Systemic Osteoporosis, Oral Bone Resorption and Tooth Loss
Periodontal Diseases
Osteoporosis and Periodontitis
Other Oral Manifestations of Menopause
Burning Mouth Syndrome
Xerostomia
Oral Mucosa
Management
Estrogen Therapy
Nonhormonal Treatment
Oral Health and Dental Management in Menopause: The Right Way to Approach (Table 10.1)
MENOPAUSE AND EYE
Dry Eye
Role of Sex Steroids
Management
Role of Hormone Therapy
Role of Androgens
Role of Tibolone
Phytoestrogens
Topical Treatment for Dry Eye
Glaucoma
Role of Hormones
Hormone Therapy and Macular Degeneration
Cataracts
KEY POINTS
CHAPTER 11:
Follow-up of Hormone Therapy
INTRODUCTION
FREQUENCY OF FOLLOW-UP
ASSESSMENT OF EFFECTIVENESS AND RISK BENEFIT RATIO
Monitor Effectiveness
Monitor Risk: Benefit Ratio
MANAGEMENT OF SIDE-EFFECTS
Estrogen-related Side-effects
Progestogen-related Side-Effects
SWITCHING FROM CYCLICAL HORMONE THERAPY TO CONTINUOUS COMBINED HORMONE THERAPY
DURATION OF USE AND ASSOCIATED RISKS
DISCONTINUATION OF HORMONE THERAPY
KEY POINTS
SECTION III: SPECIAL ISSUES
CHAPTER 12:
Menopausal Transition: A Signal to Prevent and Offset Sarcopenic Obesity
INTRODUCTION
SARCOPENIC OBESITY
RESISTANCE EXERCISE
DIET
KEY POINTS
ACKNOWLEDGMENTS
CHAPTER 13:
Cancers and Hormone Therapy
RISK OF MALIGNANCIES IN PATIENTS ON HORMONE THERAPY
Breast Cancer
Endometrial Cancer
Ovarian Cancer
Colorectal Cancer
Cervical Cancer
Other Cancers
STARTING HORMONE THERAPY AFTER CANCER TREATMENT
Hormone Therapy in Breast Cancer Survivors
Hormone Therapy in Endometrial Cancer Survivors
Hormone Therapy in Ovarian Cancer Survivors
Hormone Therapy in Cervical Cancer Survivors
Hormone Therapy in Vulvar Cancer Survivors
REDUCING CANCER RISKS OF HORMONE THERAPY
KEY POINTS
CHAPTER 14:
Cardiac Disease and Menopause
GENDER DIFFERENCES IN CORONARY ARTERY DISEASE
CHANGE IN THE RISK OF CARDIOVASCULAR DISEASE AFTER MENOPAUSE
Sex Hormones and Cardiovascular Disease Risk
Estrogen
Testosterone
MENOPAUSAL HORMONE THERAPY AND HEART DISEASE
Summary of Evidence
COUNSELING PATIENTS
KEY POINTS
CHAPTER 15:
Menopause and Cognitive Function
THE ESTROGENS AND BRAIN
Cognitive Function and Estrogen
ALZHEIMER'S DISEASE AND DEMENTIA
Hormone Therapy and Alzheimer's Disease
CURRENT GUIDELINES
ALTERNATIVE THERAPIES TO HELP IMPROVE COGNITIVE FUNCTION
Exercise
Stress Reduction
Diet
KEY POINTS
CHAPTER 16:
Nonpharmacological Management of Menopause
PROBLEM STATEMENT
VASOMOTOR SYMPTOMS
Lifestyle Measures
Phytoestrogens
Other Agents
Diet and Supplements
SLEEP AND MOOD DISTURBANCE
GENITOURINARY SYMPTOMS
MUSCULOSKELETAL SYMPTOMS
CARDIOVASCULAR DISEASE
OTHER COMPLEMENTARY INTERVENTIONS
CONCLUSION
KEY POINTS
CHAPTER 17:
Contraception in Perimenopause
PERIMENOPAUSE
Determination of the Perimenopause Age andDiagnosis of Menopause
NEED OF CONTRACEPTION DURING PERIMENOPAUSE
Unintended Pregnancy
Maternal and Fetal Risks
Change of Partner
CHOICES FOR CONTRACEPTION
Hormonal Contraceptive Methods
Combined Hormonal Contraception
Progestogen Only Contraception
Non-hormonal Contraception
Copper-bearing Intrauterine Device
Barrier Contraception
Natural Family Planning Methods
Withdrawal
Long Acting Reversible Methods of Contraception
Sterilization
STOPPING CONTRACEPTION
Non-hormonal Methods
Hormonal Methods
Removing LNG-IUS
HORMONE THERAPY AND CONTRACEPTION
FOLLOW-UP
KEY POINTS
CHAPTER 18:
Perimenopausal and Postmenopausal Obstetrics: Current Scenario
INFERTILITY IN PERIMENOPAUSAL WOMEN
TREATMENT OPTIONS FOR PERIMENOPAUSAL WOMEN
Ovarian Stimulation with In Vitro Fertilization
Oocyte Donation
ACHIEVING PREGNANCY IN POSTMENOPAUSAL WOMEN
Oocyte Donation
Method
Frozen Embryo/Gamete Transfer
Transplantation of Ovarian Tissue
Future Research
PREGNANCY COMPLICATIONS IN PERI- AND POSTMENOPAUSAL WOMEN
Early Pregnancy Complications
Late Pregnancy Complications
POINTS TO PONDER
Can a Postmenopausal Woman be a Surrogate Mother?
Can a Postmenopausal Woman Donate her Uterusfor Uterine Transplantation?
KEY POINTS
CHAPTER 19:
Abnormal Menopause
PREMATURE MENOPAUSE
Etiology
Idiopathic
Genetics
Autoimmune Disorders
Infections
Cigarette Smoking
Symptoms
Investigations
Differential Diagnosis
Treatment
SURGICAL MENOPAUSE/INDUCED MENOPAUSE
Symptoms
Treatment
Prevention
DELAYED MENOPAUSE
Investigations
Treatment
KEY POINTS
SECTION IV: DISPENSING HORMONE THERAPY
CHAPTER 20:
Counseling
RELATIONSHIP
GRIEF AND PERSONAL LOSS
EMOTIONAL CHAOS
EARLY MENOPAUSE
KEY POINTS
CHAPTER 21:
Prescription Writing
TERMINOLOGY IN HORMONE THERAPY
INDICATIONS FOR ESTROGEN THERAPY/ESTROGEN PROGESTOGEN THERAPY
CONTRAINDICATIONS AND PRECAUTIONS
HORMONAL PREPARATIONS
Estrogens
Progestogens
SHOULD PROGESTINS BE ADMINISTERED TO WOMEN AFTER HYSTERECTOMY?
REGIMENS OF HORMONE THERAPY
FOLLOW-UP
Management of the Patient with Persistent Symptoms10
Dealing with Estrogen Therapy/Estrogen Progestogen Therapy Side Effects11
PRESCRIBING HORMONE THERAPY
KEY POINTS
SECTION V: APPENDICES
APPENDIX A:
Hormonal Drugs
APPENDIX B:
Nonhormonal Drugs
APPENDIX C:
Contraception
INDEX
TOC
Index
×
Chapter Notes
Save
Clear